Adimab Collaborator GSK Receives Additional Marketing Approval for Depemokimab

– 6th Collaborator Program to Reach the Market – LEBANON, N.H., April 15, 2026 /PRNewswire/ -- Adimab, LLC, the global leader in the discovery and engineering of fully human monoclonal and multispecific antibodies, congratulates GSK plc for recently receiving approvals by the European...